Szentes B[au] - Search Results

Year	Number of Results
2018	1
2019	3
2020	3
2021	2
2022	0

1

Cost-Effectiveness of Pulmonary Rehabilitation in Patients With Bronchial Asthma: An Analysis of the EPRA Randomized Controlled Trial.

Böckmann D, Szentes BL, Schultz K, Nowak D, Schuler M, Schwarzkopf L. Böckmann D, et al. Among authors: szentes bl. Value Health. 2021 Sep;24(9):1254-1262. doi: 10.1016/j.jval.2021.01.017. Epub 2021 Apr 30. Value Health. 2021. PMID: 34452704

2

Determinants of health-related quality of life decline in interstitial lung disease.

Maqhuzu PN, Szentes BL, Kreuter M, Bahmer T, Kahn N, Claussen M, Holle R, Schwarzkopf L. Maqhuzu PN, et al. Among authors: szentes bl. Health Qual Life Outcomes. 2020 Oct 8;18(1):334. doi: 10.1186/s12955-020-01570-2. Health Qual Life Outcomes. 2020. PMID: 33032602 Free PMC article.

3

Measuring quality of life in COPD patients: comparing disease-specific supplements to the EQ-5D-5L.

Szentes BL, Schwarzkopf L, Kirsch F, Schramm A, Leidl R. Szentes BL, et al. Expert Rev Pharmacoecon Outcomes Res. 2020 Oct;20(5):523-529. doi: 10.1080/14737167.2019.1662302. Epub 2019 Sep 12. Expert Rev Pharmacoecon Outcomes Res. 2020. PMID: 31512524

4

How does the EQ-5D-5L perform in asthma patients compared with an asthma-specific quality of life questionnaire?

Szentes BL, Schultz K, Nowak D, Schuler M, Schwarzkopf L. Szentes BL, et al. BMC Pulm Med. 2020 Jun 13;20(1):168. doi: 10.1186/s12890-020-01205-8. BMC Pulm Med. 2020. PMID: 32534568 Free PMC article. Clinical Trial.

5

In-Patient Pulmonary Rehabilitation to Improve Asthma Control–A Randomized Controlled Study (EPRA, Effectiveness of Pulmonary Rehabilitation for Patients with Asthma).

Schultz K, Wittmann M, Wagner R, Lehbert N, Schwarzkopf L, Szentes B, Nowak D, Faller H, Schuler M. Schultz K, et al. Among authors: szentes b. Dtsch Arztebl Int. 2021 Jan 22;118(3):23-30. doi: 10.3238/arztebl.m2021.0003. Dtsch Arztebl Int. 2021. PMID: 33759752 Free PMC article. Clinical Trial.

6

Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L.

Szentes BL, Kreuter M, Bahmer T, Birring SS, Claussen M, Waelscher J, Leidl R, Schwarzkopf L. Szentes BL, et al. Respir Res. 2018 May 25;19(1):101. doi: 10.1186/s12931-018-0808-x. Respir Res. 2018. PMID: 29801506 Free PMC article.

7

Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study.

Lutter JI, Szentes B, Wacker ME, Winter J, Wichert S, Peters A, Holle R, Leidl R. Lutter JI, et al. Among authors: szentes b. Health Econ Rev. 2019 Aug 30;9(1):26. doi: 10.1186/s13561-019-0243-9. Health Econ Rev. 2019. PMID: 31471778 Free PMC article.

8

Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study.

Kirsch F, Schramm A, Schwarzkopf L, Lutter JI, Szentes B, Huber M, Leidl R. Kirsch F, et al. Among authors: szentes b. Respir Res. 2019 Oct 10;20(1):215. doi: 10.1186/s12931-019-1179-7. Respir Res. 2019. PMID: 31601216 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results